European drug prevention quality standards : a manual for prevention professsionals

2011·1.3 MB·English

by  EMCDDA

ME
M
A
C
N
D
U
D
A
A
L
S
European drug prevention quality standards
7
A manual for prevention professionals

European drug prevention quality standards
7
A manual for prevention professionals
Legal notice
This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is
protected by copyright. The EMCDDA accepts no responsibility or liability for any consequences
arising from the use of the data contained in the document. The contents of this publication do not
necessarily reflect the official opinions of the EMCDDA’s partners, any EU Member State or any
agency or institution of the European Union.
This publication was prepared with the Prevention Standards Partnership. The development of
the standards was co-funded (60 %) by the European Commission (EC) under the Programme of
Community Action in the field of Public Health (2003–08). Project name: ‘European standards in
evidence for drug prevention’, Project No. 2007304.
A great deal of extra information on the European Union is available on the Internet. It can be
accessed through the Europa server (http://europa.eu).
Europe Direct is a service to help you find answers to your questions about the European Union
Freephone number (*):
00 800 6 7 8 9 10 11
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed.
Cataloguing data can be found at the end of this publication.
Luxembourg: Publications Office of the European Union, 2011
ISBN: 978-92-9168-487-8
doi: 10.2810/48879
© European Monitoring Centre for Drugs and Drug Addiction, 2011
Reproduction is authorised provided the source is acknowledged. Standards must not be modified
(i.e. changed, added, or omitted) without permission from the EMCDDA/the Prevention Standards
Partnership.
Printed in Spain
Printed on white chlorine-free PaPer
Cais do Sodré, 1249-289 Lisbon, Portugal
Tel. [phone] • Fax [phone]
[email protected] • www.emcdda.europa.eu
Contents
Acknowledgements 7
Preface 11
Preface by the Prevention Standards Partnership 12
PART I: Introduction 17
Chapter 1: Current approaches to drug prevention in Europe 19
Chapter 2: Using the quality standards 25
What are the European drug prevention quality standards? 25
What definition of drug prevention is used? 26
How can the standards be used, and what is their intended purpose? 27
What can be ‘assessed’ with the standards? 31
Who should use the standards? 33
How are the standards structured, and what content do they cover? 36
What is the difference between basic and expert standards? 39
Chapter 3: About the quality standards 43
Why were the standards developed? 43
What policies do the standards support? 44
How were the standards developed? 45
What are the conditions for standards implementation, and what could be
potential barriers? 47
3
PART 2: The standards 51
Cross-cutting considerations 55
A: Sustainability and funding 57
B: Communication and stakeholder involvement 61
C: Staff development 68
D: Ethical drug prevention 74
Project stage 1: Needs assessment 83
1.1 Knowing drug-related policy and legislation 85
1.2 Assessing drug use and community needs 87
1.3 Describing the need — Justifying the intervention 92
1.4 Understanding the target population 96
Project stage 2: Resource assessment 103
2.1 Assessing target population and community resources 105
2.2 Assessing internal capacities 108
Project stage 3: Programme formulation 111
3.1 Defining the target population 113
3.2 Using a theoretical model 116
3.3 Defining aims, goals, and objectives 119
3.4 Defining the setting 124
3.5 Referring to evidence of effectiveness 127
3.6 Determining the timeline 130
Project stage 4: Intervention design 133
4.1 Designing for quality and effectiveness 135
4.2 If selecting an existing intervention 140
4.3 Tailoring the intervention to the target population 145
4.4 If planning final evaluations 148
4
Project stage 5: Management and mobilisation of resources 163
5.1 Planning the programme — Illustrating the project plan 165
5.2 Planning financial requirements 170
5.3 Setting up the team 173
5.4 Recruiting and retaining participants 177
5.5 Preparing programme materials 182
5.6 Providing a programme description 185
Project stage 6: Delivery and monitoring 189
6.1 If conducting a pilot intervention 191
6.2 Implementing the intervention 193
6.3 Monitoring the implementation 196
6.4 Adjusting the implementation 200
Project stage 7: Final evaluations 205
7.1 If conducting an outcome evaluation 207
7.2 If conducting a process evaluation 213
Project stage 8: Dissemination and improvement 219
8.1 Determining whether the programme should be sustained 221
8.2 Disseminating information about the programme 224
8.3 If producing a final report 229
Appendix 234
Original standards documents 235
Additional guidance 241
Glossary for use with the European drug prevention quality standards 245
Bibliographical references 279
5

Acknowledgements
Authors
Angelina Brotherhood, Centre for Public Health, Liverpool John Moores University, UK
Harry R. Sumnall, Centre for Public Health, Liverpool John Moores University, UK
Contributors (alphabetical order)
Franco Badii, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
Cristina Bergo, ASL di Milano, Italy
Diana Bolanu, National Anti-Drug Agency (NAA), Romania
Gregor Burkhart, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
Rosario Caruso, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
Corrado Celata, ASL di Milano, Italy
Rachele Donini, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
Katalin Felvinczi, Institute for Social Policy and Labour — National Institute for Drug Prevention
(SZMI–NDI), Hungary
Riccardo C. Gatti, ASL di Milano, Italy
Jesús Moran Iglesias, Consejeria de Sanidad — Servicio Gallego de Sanidad — Xunta de Galicia,
Spain
Artur Malczewski, National Bureau for Drug Prevention (NBDP), Poland
Roberto Mancin, ASL di Milano, Italy
Maurizio Panza, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
Francesca Romani, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
7
European drug prevention quality standards
Edit Sebestyén, Institute for Social Policy and Labour — National Institute for Drug Prevention (SZMI–
NDI), Hungary
Diana Serban, National Anti-Drug Agency (NAA), Romania
Katalin Simon, Institute for Social Policy and Labour — National Institute for Drug Prevention (SZMI–
NDI), Hungary
Nadia Vimercati, ASL di Milano, Italy
Anna Zunino, Azienda Sanitaria Locale n. 2 — Savonese (ASL2), Italy
Collaborating partners
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Institute for Alcohol and Drug Research (SIRUS), Norway
Federal Centre for Health Education (BZgA), Germany
Institute for Drugs and Drug Addictions (IDT), Portugal
Studio Consulenza e Valutazione nel Sociale (CEVAS), Italy
A list of the organisations participating in the structured consultations is available as an online
supplement to this manual at
http://www.emcdda.europa.eu/publications/manuals/prevention-standards/annex
8